INTERNATIONAL PATENT: REVIVE THERAPEUTICS LTD FILES APPLICATION FOR "COMPOSITIONS, METHODS AND USES OF BUCILLAMINE IN THE TREATMENT A VICTIM EXPOSED TO A CHEMICAL WARFARE AGENT"

GENEVA, Feb. 2 -- REVIVE THERAPEUTICS LTD (82 Richmond Street EastToronto, Ontario M5C 1P1) filed a patent application (PCT/CA2024/000008) for "COMPOSITIONS, METHODS AND USES OF BUCILLAMINE IN THE TREATMENT A VICTIM EXPOSED TO A CHEMICAL WARFARE AGENT" on Jul 29, 2024. With publication no. WO/2025/019927, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRANCK, Michael (82 Richmond Street EastToronto, Ontario M5C 1P1)

Abstract: Compositions, methods and uses for treatment of a victim exposed to a chemical agent comprisi...